Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE CHALLENGE OF AML IN OLDER PATIENTS

    Alan K Burnett
    e2013038
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.038
    2406
    PDF: 1024
    HTML: 2226
  • BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

    Lorenzo Falchi, Jessica M Baron, Carrie Anne Orlikowski, Alessandra Ferrajoli
    e2016011
    2016-02-10
    https://doi.org/10.4084/mjhid.2016.011
    4421
    PDF: 1528
    HTML: 3725
  • 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

    Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso
    e2011011
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.011
    1679
    PDF: 801
    HTML: 1124
  • THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS

    Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Sacchi
    e2011065
    2011-12-20
    https://doi.org/10.4084/mjhid.2011.065
    2738
    PDF: 791
    HTML: 2322
  • RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?

    Antonio Cuneo, Robin Foà
    e2019024
    2019-02-27
    https://doi.org/10.4084/mjhid.2019.024
    2791
    PDF: 1700
    HTML: 392
  • FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients

    Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni
    e2024066
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.066
    1094
    PDF: 650
    Html: 172
  • Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

    Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano
    e2021054
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.054
    1315
    PDF: 481
    HTML: 223
  • The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

    Shuku Sato
    e2025070
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.070
    1456
    PDF: 483
    HTML: 142
  • I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS

    guangliang Chen
    e2021053
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.053
    1239
    PDF: 531
    HTML: 411
  • OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

    Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst
    e2023025
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.025
    1457
    HTML: 396
    PDF: 995
    Suppl. Files: 487
  • Hematogenous Disseminated Pulmonary Tuberculosis in an Elderly Patient with Acute Myeloid Leukemia: A Case Report

    Yu xi Ding, Xiao Dong Liu, wenqiang kong
    e2026010
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.010
    759
    PDF: 571
    HTML: 301
  • GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

    Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis
    e2025014
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.014
    1523
    HTML: 184
    PDF: 905
  • The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma

    Sujith V Cherian, Subhraleena Das, Bandita Das Basu, Robert E Hutchison
    e2013019
    2013-02-20
    https://doi.org/10.4084/mjhid.2013.019
    1841
    PDF: 714
    HTML: 2427
    Untitled: 171
    Figure 1 a: 183
    Figure 1 b: 186
    Fig 1 c: 171
    Figure 1 d: 217
  • REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE

    Emmanuel Gyan, François Dreyfus, Pierre Fenaux
    e2015018
    2015-02-13
    https://doi.org/10.4084/mjhid.2015.018
    12936
    PDF: 1730
    HTML: 4350
    Cover letter: 222
    Figure 1: 231
  • SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

    Galila F Zaher, Soheir S Adam
    e2012021
    2012-04-02
    https://doi.org/10.4084/mjhid.2012.021
    1386
    PDF: 941
    HTML: 3622
  • Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?

    Salvatore Perrone
    e2024055
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.055
    636
    PDF: 829
    HTML: 134
  • DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA

    Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, Jaime Pérez de Oteyza, Susana Vives, Belen Vidriales, Pilar Herrera, Juan Antonio Vera, Aurelio López Martínez, Adolfo De la Fuente, María Lourdes Amador, José Ángel Hernández-Rivas, María Ángeles Fernández, Carlos Javier Cerveró, Daniel Morillo, Pilar Hernández Campo, Julián Gorrochategui, Daniel Primo, José Luis Rojas, Margarita Guenova, Joan Ballesteros, Miguel Ángel Sanz, Pau Montesinos
    e2019016
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.016
    2104
    PDF: 1149
    HTML: 323
  • TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA

    Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti
    e2014005
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.005
    3467
    PDF: 1518
    HTML: 4080
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELOID NEOPLASMS (t-MN) OF THE ADULT: MONOCENTRIC OBSERVATIONAL STUDY AND REVIEW OF THE LITERATURE.

    Elisabetta Metafuni, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Andrea Bacigalupo, Giuseppe Leone, Simona Sica
    e2018005
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.005
    4282
    PDF: 1128
    HTML: 1448
  • HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

    Armando Tripodi
    e2024027
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.027
    1070
    PDF: 1417
    HTML: 159
  • Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia

    Dina Sameh Soliman, Samah Kohla, Shehab Fareed, Susanna Akiki , Aliaa Amer, Ibrahim Ganwo, Prem Chandra, Halima El-Omri, Feryal Ibrahim
    e2022067
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.067
    1177
    PDF: 684
    HTML: 469
  • Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19

    Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca
    e2020048
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.048
    3262
    PDF: 1912
    HTML: 988
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1452
    PDF: 839
    HTML: 1027
  • Successful Treatment with Imipenem/Cilastatin/Relebactam of a Polymicrobial Bacteremia due to Meropenem/Vaborbactam-Resistant KPC-Producing Klebsiella pneumoniae and Enterococcus faecalis

    Federico Marzi, Mario Alessandri, Veronica De Crescenzo, Stefania Del Vecchio, Simone Radi, Maurizio Manini
    e2026037
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.037
    370
    HTML: 125
    PDF: 149
  • ACQUIRED REFRACTORY IRON DEFICIENCY

    Margherita Migone De Amicis, Alessandro Rimondi, Luca Elli, Irene Motta
    e2021028
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.028
    3646
    PDF: 1258
    HTML: 1394
  • ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Federico Lussana, Alessandro Rambaldi
    e2014065
    2014-10-20
    https://doi.org/10.4084/mjhid.2014.065
    2994
    PDF: 1318
    HTML: 2834
    Figure 1: 199
  • HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients

    Wenshan Yang, Wei Dong
    e2025029
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.029
    3138
    PDF: 1081
    HTML: 269
    Suppl. Files: 528
  • ACUTE MYELOİD LEUKEMİA, MYELODYSPLASİA-RELATED: BEYOND CLASSİFİCATİON—TOWARD PRECİSİON DECİSİON-MAKİNG

    G Leone, U Testa, E Attardi, MT Voso
    e2026075
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.075
    55
    PDF: 47
    Html: 5
  • PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta

    Mohamed Emara, Middle name: Hussien, Dr, Middle name: Asem, Dr, Prof., Prof., Dr.
    Page e2021033
    2021-04-29
    https://doi.org/10.4084/mjhid.2021.033
    1683
    PDF: 532
    MP4: 447
    Html: 298
  • DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.

    Maria Concetta Postorino, Filippo Luciani, Carmelo Mangano, Maria Stella Carpentieri, Paolo Scerbo, Armando Priamo, Giuseppina Berardelli, Roberto Marino, Alfredo Vallone, Nicola Serrao, Vincenzo Pisani, Chiara Costa, Albano Terremoto, Giuseppe Foti, Lucio Cosco, Massimo Calderazzo, Domenico Corigliano, Preziosa Scordo, Carlo Torti, Alessio Strazzulla
    e2015054
    2015-10-08
    https://doi.org/10.4084/mjhid.2015.054
    1664
    PDF: 846
    HTML: 1276
    Figure 1: 192
    Figure 2: 206
    Figure 3: 206
  • A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

    Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani
    e2012017
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.017
    1287
    PDF: 675
    HTML: 802
  • COBALAMIN DEFICIENCY IN THE ELDERLY

    Giacomo Marchi, Fabiana Busti, Acaynne Lira Zidanes, Alice Vianello, Domenico Girelli
    e2020043
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.043
    2721
    PDF: 2071
    HTML: 800
  • TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1

    PIMJAI NIPARUCK
    e2021063
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.063
    1255
    PDF: 591
    HTML: 261
  • THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

    Elihu Estey
    e2013050
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.050
    2238
    PDF: 779
    HTML: 1640
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1706
    PDF: 672
    HTML: 2444
  • Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India

    Mary Theresa Sylvia, Biswajit Dey, Debdatta Basu, Sajini Elizabeth Jacob, Rakhee Kar, Biswajit Dubashi
    e2016060
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.060
    3522
    PDF: 820
    HTML: 3022
    Figure 1a and 1b: 170
    Figure 2: 178
    Figure 3: 197
    Figure 4: 177
    Figure 5: 182
    Tables 1-5: 166
  • OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING REDUCED-INTENSITY CONDITIONINIG REGIMEN IN PATIENTS WITH IDIOPATHIC MYELOFIBROSIS: THE G.I.T.M.O. EXPERIENCE AND REVIEW OF THE LITERATURE

    Francesca Patriarca, Andrea Bacigalupo, Alessandra Sperotto, Miriam Isola, Maria Teresa Van Lint, Anna Paola Iori, Paolo Di Bartolomeo, Maurizio Musso, Pietro Pioltelli, Giuseppe Visani, Pasquale Iacopino, Renato Fanin, Alberto Bosi
    e2010010
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.010
    1589
    PDF: 822
    HTML: 775
  • SURVEILLANCE AND CONTROL OF ANTIBIOTIC RESISTANCE IN THE MEDITERRANEAN REGION

    Walter Ricciardi, Gabriele Giubbini, Patrizia Laurenti
    e2016036
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.036
    4235
    PDF: 1435
    HTML: 13477
  • CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL

    Abdolreza Sotoodeh Jahromi, Mohammad Kargar, Farshid Kafilzadeh, Marzieh Jamalidoust, Maliheh Moradzadeh
    e2021049
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.049
    1377
    PDF: 546
    HTML: 294
  • A case of severe gastrointestinal toxicity after allogeneic hematopoietic stem cell transplantation: can we improve the evaluation of the “gut fitness“ ?

    Gabriele Magliano, Enrico Morello, Mirko Farina, Vera Radici, Marco Galli, giulia brambilla, Michele Malagola, Domenico Russo, Daniele Avenoso
    e2025054
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.054
    744
    PDF: 551
    HTML: 107
  • PATHOBIOLOGY OF HODGKIN LYMPHOMA

    Claudio Agostinelli, Stefano Pileri
    e2014040
    2014-06-05
    https://doi.org/10.4084/mjhid.2014.040
    3347
    PDF: 1511
    HTML: 5966
    Fig1-Ag-Pil: 259
    Ag-Pil Fig.2: 259
  • HHVs AND LYMPHOPROLIFERATIVE DISORDERS

    C Quadrelli, P Barozzi, G Riva, Mario Luppi
    e2011043
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.043
    1472
    PDF: 854
    HTML: 3136
  • ANALYSIS OF PROGNOSTIC RISK FACTORS OF BLOODSTREAM INFECTIONS IN BEIJING COMMUNITIES: A RETROSPECTIVE STUDY FROM 2015 TO 2019

    Yan Liu, Beichen Cui, Chunmei Pi, Xiaohong Yu, Zhiwei Liu, Xiang Li, Liping Ma, Cong Wang
    e2021060
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.060
    920
    PDF: 409
    HTML: 172
  • Community-acquired Carbapenem-resistant Escherichia coli Bacteremia Complicated by c: A Case Report

    Yu Chen, Jin Zhang, wenqiang kong
    e2026005
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.005
    615
    PDF: 499
    HTML: 149
  • NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

    Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso
    e2010021
    2010-08-11
    https://doi.org/10.4084/mjhid.2010.021
    2065
    PDF: 1585
    HTML: 803
  • SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival

    Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil
    e2021006
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.006
    2138
    PDF: 882
    HTML: 360
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

    Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
    e2012069
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.069
    2613
    PDF: 761
    HTML: 1643
  • Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

    Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti
    e2022043
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.043
    1724
    PDF: 623
    HTML: 255
  • Extending Long Term Follow-up of Patient With Acute Myeloid Leukemia after Autologous Stem Cell Transplantation: disclosing late mortality and causes of death.

    Federica Sorà, Patrizia Chiusolo, luca laurenti, idanna innocenti, francesco autore, andrea corbingi, andrea corbingi, sabrina giammarco, elisabetta metafuni, andrea bacigalupo, simona sica
    e2020030
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.030
    1493
    PDF: 641
    HTML: 222
  • ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS

    Anna Maria Testi, Francesco Lococo
    e2014032
    2014-04-15
    https://doi.org/10.4084/mjhid.2014.032
    2911
    PDF: 1733
    HTML: 2369
51 - 100 of 196 items << < 1 2 3 4 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.